Mitotane effects in a H295R xenograft model of adjuvant treatment of adrenocortical cancer

Hormone and Metabolic Research

Volumn 42, Issue 10, 2010, Pages 725-730

  Lindhe, O ^a,b   Skogseid, B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b BIACORE AB   (Sweden)

Author keywords

adjuvant; adrenocortical; H295R; mitotane; xenograft

Indexed keywords

3 METHYLSULFONYL 2,2' BIS( 4 CHLOROPHENYL) 1,1' DICHLOROETHENE; ANTINEOPLASTIC AGENT; ARACHIS OIL; FLUORODEOXYGLUCOSE F 18; LEVO TYROSINE F 18; METHIONINE C 11; METOMIDATE C 11; MITOTANE; TRACER; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADRENAL CANCER; ADRENOCORTICAL CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOACCUMULATION; CANCER ADJUVANT THERAPY; CANCER CELL; CANCER CELL CULTURE; CANCER INHIBITION; CELL AGGREGATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG METABOLISM; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INJECTION; INOCULATION; MOUSE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TUMOR CELL; TUMOR GROWTH; XENOGRAFT;

ADJUVANTS, PHARMACEUTIC; ADRENAL CORTEX NEOPLASMS; ANIMALS; CELL AGGREGATION; CELL COUNT; CELL PROLIFERATION; FEMALE; HUMANS; MICE; MITOTANE; POSITRON-EMISSION TOMOGRAPHY; RADIOACTIVE TRACERS; SPHEROIDS, CELLULAR; TIME FACTORS; TUMOR BURDEN; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; MUS MUSCULUS;

EID: 77956444150     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0030-1261923     Document Type: Article

References (35)

1. Terzolo M, Angeli A, Fassnacht M, Daffara F, Tauchmanova L, Conton PA, Rossetto R, Buci L, Sperone P, Grossrubatscher E, Reimondo G, Bollito E, Papotti M, Saeger W, Hahner S, Koschker AC, Arvat E, Ambrosi B, Loli P, Lombardi G, Mannelli M, Bruzzi P, Mantero F, Allolio B, Dogliotti L, Berruti A. Adjuvant mitotane treatment for adrenocortical carcinoma. N Engl J Med 2007 356 2372-2380
2. Huang H, Fojo T. Adjuvant mitotane for adrenocortical cancer a recurring controversy. J Clin Endocrinol Metab 2008 93 3730-3732
3. Wooten MD, King DK. Adrenal cortical carcinoma: Epidemiology and treatment with mitotane and a review of the literature. Cancer 1993 72 3145-3155
4. Hart MM, Reagan RL, Adamson RH. The effect of isomers of DDD on the ACTH-induced steroid output, histology and ultrastructure of the dog adrenal cortex. Toxicol Appl Pharmacol 1973 24 101-113
5. Terzolo M, Pia A, Berruti A, Osella G, Ali A, Carbone V, Testa E, Dogliotti L, Angeli A. Low-dose monitored mitotane treatment achieves the therapeutic range with manageable side effects in patients with adrenocortical cancer. J Clin Endocrinol Metab 2000 85 2234-2238
6. Wajchenberg BL, Albergaria Pereira MA, Medonca BB, Latronico AC, Campos Carneiro P, Ferreira Alves VA, Zerbini MC, Liberman B, Carlos Gomes G, Kirschner MA. Adrenocortical carcinoma: clinical and laboratory observations. Cancer 2000 88 711-736
7. Lund BO, Bergman , Brandt I. Metabolic activation and toxicity of a DDT-metabolite, 3-methylsulphonyl-DDE, in the adrenal zona fasciculata in mice. Chem Biol Interact 1988 65 25-40
8. Ulleras E, Ohlsson A, Oskarsson A. Secretion of cortisol and aldosterone as a vulnerable target for adrenal endocrine disruption screening of 30 selected chemicals in the human H295R cell model. J Appl Toxicol 2008 28 1045-1053
9. Jnsson C-J, Rodriguez Martinez H, Lund BO, Bergman , Brandt I. Adrenocortical toxicity of 3-methylsulfonyl-DDE in mice. II. Mitochondrial changes following ecologically relevant doses. Fundam Appl Toxicol 1991 16 365-374
10. Lund BO, Lund J. Novel involvement of a mitochondrial steroid hydroxylase (P450c11) in xenobiotic metabolism. J Biol Chem 1995 270 20895-20897
11. Domalik LJ, Chaplin DD, Kirkman MS, Wu RC, Liu WW, Howard TA, Seldin MF, Parker KL. Different isozymes of mouse 11 beta-hydroxylase produce mineralocorticoids and glucocorticoids. Mol Endocrinol 1991 5 1853-1861
12. Lindhe Ö, Lund B-O, Bergman , Brandt I. Irreversible binding and adrenocorticolytic activity of the DDT metabolite 3-methylsulphonyl-DDE examined in tissue slice culture. Environ Health Perspect 2001 109 105-110
13. Lindhe Ö, Skogseid B, Brandt I. Cytochrome P450-catalysed binding of 3-methylsulfonyl-DDE and o,p -DDD in human adrenal zona fasciculata/ reticularis. J Clin Endocrinol Metabol 2002 87 1319-1326
14. Gazdar AF, Oie HK, Shackleton CH, Chen TR, Triche TJ, Myers CE, Chrousos GP, Brennan MF, Stein CA, La Rocca RV. Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res 1990 50 5488-5496
15. Rainey WE, Bird IM, Mason JI. The NCI-H295 cell line: a pluripotent model for human adrenocortical studies. Mol Cell Endocrinol 1994 100 45-50
16. 2-DDE and some CYP inhibitors on glucocorticoid steroidogenesis in the H295R human adrenocortical carcinoma cell line. Toxicol In Vitro 2002 16 91-99
17. Cobb VJ, Williams BC, Mason JI, Walker SW. Forskolin treatment directs steroid production towards the androgen pathway in the NCI-H295R adrenocortical tumour cell line. Endocr Res 1996 22 545-550
18. Rainey WE, Bird IM, Sawetawan C, Hanley NA, McCarthy JL, McGee EA, Wester R, Mason JI. Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids. J Clin Endocrinol Metab 1993 77 731-737
19. Mountjoy KG, Bird IM, Rainey WE, Cone RD. ACTH induces up-regulation of ACTH receptor mRNA in mouse and human adrenocortical cell lines. Mol Cell Endocrinol 1994 99 R17-R20
20. Ozbay T, Merrill AH Jr, Sewer MB. ACTH regulates steroidogenic gene expression and cortisol biosynthesis in the human adrenal cortex via sphingolipid metabolism. Endocr Res 2004 30 787-794
21. Fassnacht M, Hahner S, Beuschlein F, Klink A, Reincke M, Allolio B. New mechanisms of adrenostatic compounds in a human adrenocortical cancer cell line. Eur J Clin Invest 2000 3 76-82
22. Oskarsson A, Ulleras E, Plant KE, Hinson JP, Goldfarb PS. Steroidogenic gene expression in H295R cells and the human adrenal gland: adrenotoxic effects of lindane in vitro. J Appl Toxicol 2006 26 484-492
23. Logie A, Boudou P, Boccon-Gibod L, Baudin E, Vassal G, Schlumberger M, Le Bouc Y, Gicquel C. Establishment and characterization of a human adrenocortical carcinoma xenograft model. Endocrinology 2000 141 3165-3171
24. Barlaskar FM, Spalding AC, Heaton JH, Kuick R, Kim AC, Thomas DG, Giordano TJ, Ben-Josef E, Hammer GD. Preclinical targeting of the type I insulin-like growth factor receptor in adrenocortical carcinoma. J Clin Endocrinol Metab 2009 94 204-212
25. 11C]. metomidate positron emission tomography of adrenocortical tumors in correlation with histopathological findings. J Clin Endocrinol Metab 2006 91 1410-1414
26. Han SJ, Kim TS, Jeon SW, Jeong SJ, Yun M, Rhee Y, Kang ES, Cha BS, Lee EJ, Lee HC, Lim SK. Analysis of adrenal masses by 18F-FDG positron emission tomography scanning. Int J Clin Practice 2007 61 802-809
27. Bergman , Wachtmeister CA. Synthesis of methanesulfonyl derivates of 2,2-bis (4-chlorophenyl)-1,1-dichloroethylene (p,p-DDE) present in seal from the Baltic. Acta Chem Scand 1977 B31 90-91
28. Monazzam A, Razifar P, Lindhe O, Josephsson R, Langstrom B, Bergstrom M. A new, fast and semi-automated size determination method (SASDM) for studying multicellular tumor spheroids. Cancer Cell Int 2005 5 32
29. Lund BO, Bergman A, Brandt I. In vitro macromolecular binding of 2-(2-chlorophenyl)-2-(4-chlorophenyl)-1,1-dichloroethane (o,p -DDD) in the mouse lung and liver. Chem Biol Interact 1989 70 63-72
30. Lund BO, Klasson Wehler E, Brandt I. o,p -DDD in the mouse lung: selective uptake, covalent binding and effect on drug metabolism. Chem Biol Interact 1986 60 129-141
31. Cai W, Counsell RE, Schteingart DE, Sinsheimer JE, Vaz ADN, Wotring LL. Adrenal proteins bound by a reactive intermediate of mitotane. Cancer Chemother Pharmacol 1997 39 537-540
32. Khaitan D, Chandna S, Arya MB, Dwarakanath BS. Establishment and characterization of multicellular spheroids from a human glioma cell line; Implications for tumor therapy. J Transl Med 2006 4 12
33. Khoei S, Goliaei B, Neshasteh-Riz A, Deizadji A. The role of heat shock protein 70 in the thermoresistance of prostate cancer cell line spheroids. FEBS Lett 2004 561 144-148
34. Mueller-Klieser W. 3-dimensional cell cultures: from molecular mechanisms to clinical applications. Am J Physiol 1997 273 C1109-C1123 (Pubitemid 127797683)
35. Lindstrom V, Brandt I, Lindhe O. Species differences in 3-methylsulphonyl-DDE bioactivation by adrenocortical tissue. Arch Toxicol 2008 82 159-163